Laura Thoma

1.5k total citations
27 papers, 1.2k citations indexed

About

Laura Thoma is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Laura Thoma has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Biomaterials and 4 papers in Pharmaceutical Science. Recurrent topics in Laura Thoma's work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (7 papers) and Glycosylation and Glycoproteins Research (3 papers). Laura Thoma is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (7 papers) and Glycosylation and Glycoproteins Research (3 papers). Laura Thoma collaborates with scholars based in United States, India and South Korea. Laura Thoma's co-authors include G. Christopher Wood, Pavan Balabathula, Bivash Mandal, Nivesh Mittal, Duane D. Miller, Ajit S. Narang, Ram I. Mahato, Himanshu Bhattacharjee, Hongkee Sah and Bob Moore and has published in prestigious journals such as Pharmaceutical Research, Bioconjugate Chemistry and European Journal of Pharmaceutical Sciences.

In The Last Decade

Laura Thoma

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Thoma United States 12 528 418 331 225 107 27 1.2k
Pavan Balabathula United States 9 307 0.6× 349 0.8× 208 0.6× 195 0.9× 79 0.7× 14 722
Amal K. Hussein Egypt 16 500 0.9× 386 0.9× 482 1.5× 194 0.9× 71 0.7× 33 1.4k
Shivani Rai Paliwal India 21 566 1.1× 539 1.3× 570 1.7× 371 1.6× 71 0.7× 37 1.6k
Bivash Mandal United States 9 271 0.5× 339 0.8× 258 0.8× 178 0.8× 74 0.7× 13 729
Carolin Weber Germany 7 433 0.8× 453 1.1× 170 0.5× 203 0.9× 63 0.6× 9 946
Farnaz Esmaeili Iran 11 261 0.5× 428 1.0× 257 0.8× 191 0.8× 57 0.5× 14 762
Kristin H. Loomis United States 14 720 1.4× 438 1.0× 224 0.7× 263 1.2× 65 0.6× 15 1.4k
Aviral Jain India 20 388 0.7× 372 0.9× 483 1.5× 153 0.7× 45 0.4× 49 1.2k
Diana Rafael Spain 21 490 0.9× 410 1.0× 159 0.5× 385 1.7× 127 1.2× 42 1.2k
Diana Guimarães Portugal 7 470 0.9× 373 0.9× 181 0.5× 260 1.2× 57 0.5× 12 1.0k

Countries citing papers authored by Laura Thoma

Since Specialization
Citations

This map shows the geographic impact of Laura Thoma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Thoma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Thoma more than expected).

Fields of papers citing papers by Laura Thoma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Thoma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Thoma. The network helps show where Laura Thoma may publish in the future.

Co-authorship network of co-authors of Laura Thoma

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Thoma. A scholar is included among the top collaborators of Laura Thoma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Thoma. Laura Thoma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mittal, Nivesh, Bivash Mandal, Pavan Balabathula, et al.. (2018). Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies. Pharmaceutics. 10(2). 50–50. 5 indexed citations
3.
Mandal, Bivash, Nivesh Mittal, Pavan Balabathula, Laura Thoma, & G. Christopher Wood. (2015). Development and in vitro evaluation of core–shell type lipid–polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer. European Journal of Pharmaceutical Sciences. 81. 162–171. 146 indexed citations
4.
Wood, G. Christopher, et al.. (2015). Non-Invasive Detection of Lung Inflammation by Near-Infrared Fluorescence Imaging Using Bimodal Liposomes. Journal of Fluorescence. 26(1). 241–253. 10 indexed citations
5.
Mittal, Nivesh, Himanshu Bhattacharjee, Bivash Mandal, et al.. (2014). Targeted liposomal drug delivery systems for the treatment of B cell malignancies. Journal of drug targeting. 22(5). 372–386. 11 indexed citations
6.
Balabathula, Pavan, et al.. (2014). Optimization of drug loading to improve physical stability of paclitaxel-loaded long-circulating liposomes. Journal of Liposome Research. 25(4). 308–315. 32 indexed citations
7.
Balabathula, Pavan, et al.. (2014). Effect of sucrose as a lyoprotectant on the integrity of paclitaxel-loaded liposomes during lyophilization. Journal of Liposome Research. 25(4). 270–278. 42 indexed citations
8.
Balabathula, Pavan, Dileep R. Janagam, Nivesh Mittal, et al.. (2013). Rapid Quantitative Evaluation of Amphotericin B in Human Plasma, by Validated HPLC Method. Journal of Bioequivalence & Bioavailability. 5(3). 8 indexed citations
9.
Mandal, Bivash, Himanshu Bhattacharjee, Nivesh Mittal, et al.. (2012). Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform. Nanomedicine Nanotechnology Biology and Medicine. 9(4). 474–491. 369 indexed citations
10.
Wood, G. Christopher, Christopher B. Pattillo, Robert C. Scott, et al.. (2006). A tumor vasculature targeted liposome delivery system for combretastatin A4: Design, characterization, and in vitro evaluation. AAPS PharmSciTech. 7(2). E7–E16. 63 indexed citations
11.
Narang, Ajit S., Laura Thoma, Duane D. Miller, & Ram I. Mahato. (2004). Cationic Lipids with Increased DNA Binding Affinity for Nonviral Gene Transfer in Dividing and Nondividing Cells. Bioconjugate Chemistry. 16(1). 156–168. 42 indexed citations
12.
Wood, George W., et al.. (2004). Cryoprotection mechanisms of polyethylene glycols on lactate dehydrogenase during freeze-thawing. The AAPS Journal. 6(3). 45–54. 19 indexed citations
13.
Sweatman, Trevor W., et al.. (2004). Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma. The Journal of Pediatric Pharmacology and Therapeutics. 9(2). 126–132. 3 indexed citations
14.
Robinson, Lawrence R., et al.. (2003). Weight Variability of Scored and Unscored Split Psychotropic Drug Tablets. Hospital Pharmacy. 38(10). 930–934. 7 indexed citations
15.
Mahato, Ram I., Ajit S. Narang, Laura Thoma, & Duane D. Miller. (2003). Emerging Trends in Oral Delivery of Peptide and Protein Drugs. Critical Reviews in Therapeutic Drug Carrier Systems. 20(2-3). 153–214. 262 indexed citations
16.
Wieting, R. D., et al.. (2002). A more elemental examination of factors governing PV module environmental stability. 1. 901–904. 1 indexed citations
17.
Wood, George W., et al.. (2002). Effects of polyethylene glycol molecular weight and concentration on lactate dehydrogenase activity in solution and after freeze-thawing.. PubMed. 56(3). 115–23. 7 indexed citations
18.
Wolfe, Janet L., Laura Thoma, Chengan Du, et al.. (1999). Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection. American Journal of Health-System Pharmacy. 56(10). 985–989. 12 indexed citations
19.
Holley, William H., et al.. (1994). Investigation into the causes of browning in EVA encapsulated flat plate PV modules. 893–896 vol.1. 37 indexed citations
20.
White, Robert D., et al.. (1992). ICE-PAVEMENT BOND PREVENTION: SURFACE MODIFICATION. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026